QQQ   426.91 (+0.25%)
AAPL   167.63 (-0.22%)
MSFT   412.94 (+0.27%)
META   497.50 (+0.67%)
GOOGL   155.70 (+0.15%)
AMZN   181.90 (+0.34%)
TSLA   151.57 (-2.50%)
NVDA   848.00 (+0.91%)
AMD   154.40 (+0.25%)
NIO   3.90 (-0.26%)
BABA   69.10 (+0.41%)
T   16.12 (+0.19%)
F   12.06 (+0.17%)
MU   117.30 (+0.83%)
GE   155.77 (+0.06%)
CGC   6.50 (+0.15%)
DIS   112.90 (-0.04%)
AMC   2.98 (+9.56%)
PFE   25.42 (-1.05%)
PYPL   63.47 (+0.33%)
XOM   118.80 (+0.14%)
QQQ   426.91 (+0.25%)
AAPL   167.63 (-0.22%)
MSFT   412.94 (+0.27%)
META   497.50 (+0.67%)
GOOGL   155.70 (+0.15%)
AMZN   181.90 (+0.34%)
TSLA   151.57 (-2.50%)
NVDA   848.00 (+0.91%)
AMD   154.40 (+0.25%)
NIO   3.90 (-0.26%)
BABA   69.10 (+0.41%)
T   16.12 (+0.19%)
F   12.06 (+0.17%)
MU   117.30 (+0.83%)
GE   155.77 (+0.06%)
CGC   6.50 (+0.15%)
DIS   112.90 (-0.04%)
AMC   2.98 (+9.56%)
PFE   25.42 (-1.05%)
PYPL   63.47 (+0.33%)
XOM   118.80 (+0.14%)
QQQ   426.91 (+0.25%)
AAPL   167.63 (-0.22%)
MSFT   412.94 (+0.27%)
META   497.50 (+0.67%)
GOOGL   155.70 (+0.15%)
AMZN   181.90 (+0.34%)
TSLA   151.57 (-2.50%)
NVDA   848.00 (+0.91%)
AMD   154.40 (+0.25%)
NIO   3.90 (-0.26%)
BABA   69.10 (+0.41%)
T   16.12 (+0.19%)
F   12.06 (+0.17%)
MU   117.30 (+0.83%)
GE   155.77 (+0.06%)
CGC   6.50 (+0.15%)
DIS   112.90 (-0.04%)
AMC   2.98 (+9.56%)
PFE   25.42 (-1.05%)
PYPL   63.47 (+0.33%)
XOM   118.80 (+0.14%)
QQQ   426.91 (+0.25%)
AAPL   167.63 (-0.22%)
MSFT   412.94 (+0.27%)
META   497.50 (+0.67%)
GOOGL   155.70 (+0.15%)
AMZN   181.90 (+0.34%)
TSLA   151.57 (-2.50%)
NVDA   848.00 (+0.91%)
AMD   154.40 (+0.25%)
NIO   3.90 (-0.26%)
BABA   69.10 (+0.41%)
T   16.12 (+0.19%)
F   12.06 (+0.17%)
MU   117.30 (+0.83%)
GE   155.77 (+0.06%)
CGC   6.50 (+0.15%)
DIS   112.90 (-0.04%)
AMC   2.98 (+9.56%)
PFE   25.42 (-1.05%)
PYPL   63.47 (+0.33%)
XOM   118.80 (+0.14%)

Virpax Pharmaceuticals (VRPX) Institutional Ownership

$3.47
0.00 (0.00%)
(As of 04/17/2024 ET)

Institutional Ownership Changes (13F Filings) for Virpax Pharmaceuticals (NASDAQ:VRPX)

Current
Institutional Ownership
Percentage
32.23%
Number of
Institutional Buyers
(last 12 months)
0
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$3.11M
Get VRPX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Virpax Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

VRPX Institutional Buying and Selling by Quarter

Virpax Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2023Sabby Management LLC292,790$234K0.2%-26.8%2.500%
5/16/2023Sabby Management LLC701,455$551K0.5%-29.0%5.988%
2/13/2023Renaissance Technologies LLC96,200$60K0.0%-39.2%0.822%
11/15/2022Vanguard Group Inc.370,884$441K0.0%+8.5%3.166%
11/14/2022Renaissance Technologies LLC158,322$188K0.0%-22.1%1.352%
8/13/2022Renaissance Technologies LLC203,200$341K0.0%+29.8%1.735%
5/13/2022Renaissance Technologies LLC156,600$348K0.0%N/A1.337%
5/13/2022Vanguard Group Inc.341,977$759K0.0%+4.5%2.918%
5/13/2022Warberg Asset Management LLC17,710$39K0.0%N/A0.151%
5/12/2022Citigroup Inc.12,179$27K0.0%N/A0.104%
11/17/2021Altium Capital Management LP271,846$1.31M0.3%N/A2.320%
11/16/2021National Asset Management Inc.18,600$90K0.0%N/A0.159%
11/2/2021Cambridge Investment Research Advisors Inc.19,420$93K0.0%N/A0.166%
9/17/2021Virtu Financial LLC23,625$107K0.0%N/A0.468%
8/16/2021Sabby Management LLC154,737$704K0.1%-22.6%3.120%
8/12/2021Saltoro Capital LP17,615$80K0.0%-34.8%0.355%
5/14/2021HN Saltoro Capital LP27,000$127K0.0%N/A0.546%
(Data available from 1/1/2016 forward)

VRPX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of VRPX shares?

During the previous two years, the following institutional investors and hedge funds held shares of Virpax Pharmaceuticals shares: Vanguard Group Inc. ($441K), Sabby Management LLC ($234K), Renaissance Technologies LLC ($60K), and Warberg Asset Management LLC ($39K), Citigroup Inc. ($27K).Learn more on VRPX's institutional investors.

What percentage of Virpax Pharmaceuticals stock is owned by institutional investors?

32.23% of Virpax Pharmaceuticals stock is owned by institutional investors. Learn more on VRPX's institutional investor holdings.

Which institutional investors have been buying Virpax Pharmaceuticals stock?

The following institutional investors have purchased Virpax Pharmaceuticals stock in the last 24 months: Renaissance Technologies LLC ($203.20K), Vanguard Group Inc. ($43.58K), Warberg Asset Management LLC ($17.71K), and Citigroup Inc. ($12.18K).

How much institutional buying is happening at Virpax Pharmaceuticals?

Institutional investors have bought a total of 276,668 shares in the last 24 months. This purchase volume represents approximately $5.59M in transactions.

Which Virpax Pharmaceuticals major shareholders have been selling company stock?

The following institutional investors have sold Virpax Pharmaceuticals stock in the last 24 months: Sabby Management LLC ($393.92K), and Renaissance Technologies LLC ($107K).

How much institutional selling is happening at Virpax Pharmaceuticals?

Institutional investors have sold a total of 500,920 shares in the last 24 months. This volume of shares sold represents approximately $4.03M in transactions.


This page (NASDAQ:VRPX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners